FLRAX
Price
$47.85
Change
+$0.15 (+0.31%)
Updated
Aug 21 closing price
Net Assets
50.18M
FXAIX
Price
$265.83
Change
-$2.30 (-0.86%)
Updated
Aug 20 closing price
Net Assets
833.14B
Interact to see
Advertisement

FLRAX vs FXAIX

FLRAX vs FXAIX Comparison Chart in %
View a ticker or compare two or three
VS
FLRAX vs. FXAIX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FLRAX is a StrongBuy and FXAIX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FXAIX has more cash in the bank: 833B vs. FLRAX (50.2M). FXAIX pays higher dividends than FLRAX: FXAIX (1.06) vs FLRAX (0.17). FLRAX was incepted earlier than FXAIX: FLRAX (24 years) vs FXAIX (15 years). FLRAX (1.26) is less costly to investors than FXAIX (0.01). FLRAX is a more actively managed with annual turnover of: 70.00 vs. FXAIX (3.00). FXAIX has a lower initial minimum investment than FLRAX: FXAIX (0) vs FLRAX (3000). FXAIX annual gain was more profitable for investors over the last year : 21.35 vs. FLRAX (10.98). FXAIX return over 5 years is better than : 84.67 vs. FLRAX (10.80).
FLRAXFXAIXFLRAX / FXAIX
Total Expense Ratio1.010.016,733%
Annual Report Gross Expense Ratio1.260.018,400%
Fund Existence24 years15 years-
Gain YTD10.22812.43782%
Front Load6%N/A-
Min. Initial Investment30000-
Min. Initial Investment IRAN/AN/A-
Net Assets50.2M833B0%
Annual Yield % from dividends0.171.0616%
Returns for 1 year10.9821.3551%
Returns for 3 years43.7981.1554%
Returns for 5 years10.8084.6713%
Returns for 10 years130.70286.5746%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYCFX55.570.84
+1.53%
Rydex Biotechnology C
RSLBX70.040.57
+0.82%
American Funds SMALLCAP World R-2
RYPNX20.180.16
+0.80%
Royce Small-Cap Opportunity Invmt
VSORX54.480.35
+0.65%
Victory Sycamore Small Company Opp R6
BLNIX15.060.05
+0.33%
Meeder Balanced Institutional